fda warning letters compounded semaglutide tirzepatide 2025 Issues 30 to Telehealth Firms Over Misleading GLP-1 Marketing FDA Warning Letter Breakdown: Sterility

The Swiss study compared 1.5 mg weekly doses of dulaglutide (Trulicity, Eli Lilly) with placebo, varenicline and counseling as a control for 12-week abstinence confirmed by carbon monoxide breath testing

Sounds intriguing, right

In some cases, yes, you may qualify for free access through manufacturer assistance programs, certain Medicare Advantage plans, or comprehensive insurance coverage

Steinberg I

Understanding these mechanisms helps contextualize why hair changes might occur during treatment with weight loss medications like tirzepatide, even if the medication itself is not directly affecting hair follicles

Copper toxicity Though its unlikely, copper peptide skin care products may lead to potential copper toxicity if not used as directed by the manufacturer (or if multiple copper-containing products are used together)